Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52


DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.

Chen CW, Koche RP, Sinha AU, Deshpande AJ, Zhu N, Eng R, Doench JG, Xu H, Chu SH, Qi J, Wang X, Delaney C, Bernt KM, Root DE, Hahn WC, Bradner JE, Armstrong SA.

Nat Med. 2015 Apr;21(4):335-43. doi: 10.1038/nm.3832. Epub 2015 Mar 30.


Notch-mediated expansion of cord blood progenitors: maintenance of transcriptional and epigenetic fidelity.

Dahlberg A, Woo S, Delaney C, Boyle P, Gnirke A, Bock C, Bernstein BE, Meissner A, Gottardo R, Bernstein ID.

Leukemia. 2015 Mar 6. doi: 10.1038/leu.2015.61. [Epub ahead of print] No abstract available.


One-unit versus two-unit cord-blood transplantation for hematologic cancers.

Wagner JE Jr, Eapen M, Carter S, Wang Y, Schultz KR, Wall DA, Bunin N, Delaney C, Haut P, Margolis D, Peres E, Verneris MR, Walters M, Horowitz MM, Kurtzberg J; Blood and Marrow Transplant Clinical Trials Network.

N Engl J Med. 2014 Oct 30;371(18):1685-94. doi: 10.1056/NEJMoa1405584.


Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.

Burroughs LM, Nemecek ER, Torgerson TR, Storer BE, Talano JA, Domm J, Giller RH, Shimamura A, Delaney C, Skoda-Smith S, Thakar MS, Baker KS, Rawlings DJ, Englund JA, Flowers ME, Deeg HJ, Storb R, Woolfrey AE.

Biol Blood Marrow Transplant. 2014 Dec;20(12):1996-2003. doi: 10.1016/j.bbmt.2014.08.020. Epub 2014 Sep 6.


Enhanced generation of cord blood hematopoietic stem and progenitor cells by culture with StemRegenin1 and Delta1(Ext-IgG.).

Dahlberg A, Brashem-Stein C, Delaney C, Bernstein ID.

Leukemia. 2014 Oct;28(10):2097-101. doi: 10.1038/leu.2014.181. Epub 2014 Jun 6. No abstract available.


Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review.

Augestad KM, Rose J, Crawshaw B, Cooper G, Delaney C.

World J Gastrointest Oncol. 2014 May 15;6(5):104-11. doi: 10.4251/wjgo.v6.i5.104. Review.


Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia.

Bar M, Wood BL, Radich JP, Doney KC, Woolfrey AE, Delaney C, Appelbaum FR, Gooley TA.

Leuk Res Treatment. 2014;2014:421723. doi: 10.1155/2014/421723. Epub 2014 Mar 23.


Late-onset colitis after cord blood transplantation is consistent with graft-versus-host disease: results of a blinded histopathological review.

Milano F, Shulman HM, Guthrie KA, Riffkin I, McDonald GB, Delaney C.

Biol Blood Marrow Transplant. 2014 Jul;20(7):1008-13. doi: 10.1016/j.bbmt.2014.03.020. Epub 2014 Apr 3.


Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.

Gyurkocza B, Gutman J, Nemecek ER, Bar M, Milano F, Ramakrishnan A, Scott B, Fang M, Wood B, Pagel JM, Baumgart J, Delaney C, Maziarz RT, Sandmaier BM, Estey EH, Appelbaum FR, Storer BE, Deeg HJ.

Biol Blood Marrow Transplant. 2014 Apr;20(4):549-55. doi: 10.1016/j.bbmt.2014.01.009. Epub 2014 Jan 16.


A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer.

Chan J, Kinsella MT, Willis JE, Hu H, Reynolds H Jr, Delaney C, McCulla A, Deharo S, Ahdesmäki M, Allen WL, Johnston PG, Kinsella TJ.

Front Oncol. 2013 Nov 25;3:288. doi: 10.3389/fonc.2013.00288. eCollection 2013.


Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission.

Walter RB, Buckley SA, Pagel JM, Wood BL, Storer BE, Sandmaier BM, Fang M, Gyurkocza B, Delaney C, Radich JP, Estey EH, Appelbaum FR.

Blood. 2013 Sep 5;122(10):1813-21. doi: 10.1182/blood-2013-06-506725. Epub 2013 Jul 11.


CD34(+) expansion with Delta-1 and HOXB4 promotes rapid engraftment and transfusion independence in a Macaca nemestrina cord blood transplant model.

Watts KL, Delaney C, Nelson V, Trobridge GD, Beard BC, Humphries RK, Kiem HP.

Mol Ther. 2013 Jun;21(6):1270-8. doi: 10.1038/mt.2013.40. Epub 2013 Apr 16.


Characteristics of chronic GVHD after cord blood transplantation.

Newell LF, Flowers ME, Gooley TA, Milano F, Carpenter PA, Martin PJ, Delaney C.

Bone Marrow Transplant. 2013 Oct;48(10):1285-90. doi: 10.1038/bmt.2013.48. Epub 2013 Apr 15.


Graft-versus-host-disease after double cord blood transplantation: a new look at its characteristics.

Milano F, Delaney C, Storb R.

Biol Blood Marrow Transplant. 2013 Jun;19(6):847-8. doi: 10.1016/j.bbmt.2013.04.006. Epub 2013 Apr 10. No abstract available.


Diet influences expression of autoimmune-associated genes and disease severity by epigenetic mechanisms in a transgenic mouse model of lupus.

Strickland FM, Hewagama A, Wu A, Sawalha AH, Delaney C, Hoeltzel MF, Yung R, Johnson K, Mickelson B, Richardson BC.

Arthritis Rheum. 2013 Jul;65(7):1872-81. doi: 10.1002/art.37967.


Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulin.

Ostronoff F, Milano F, Gooley T, Gutman JA, McSweeney P, Petersen FB, Sandmaier BM, Storb R, Delaney C.

Bone Marrow Transplant. 2013 Jun;48(6):782-6. doi: 10.1038/bmt.2012.243. Epub 2012 Dec 17.


Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia.

Scaradavou A, Brunstein CG, Eapen M, Le-Rademacher J, Barker JN, Chao N, Cutler C, Delaney C, Kan F, Isola L, Karanes C, Laughlin MJ, Wagner JE, Shpall EJ.

Blood. 2013 Jan 31;121(5):752-8. doi: 10.1182/blood-2012-08-449108. Epub 2012 Dec 9.


Cord blood graft engineering.

Delaney C, Bollard CM, Shpall EJ.

Biol Blood Marrow Transplant. 2013 Jan;19(1 Suppl):S74-8. doi: 10.1016/j.bbmt.2012.10.015. Epub 2012 Oct 17. Review. No abstract available.


Surgical quality surrogates do not predict colon cancer survival in the setting of technical credentialing: a report from the prospective COST trial.

Mathis KL, Green EM, Sargent DJ, Delaney C, Simmang CL, Nelson H.

Ann Surg. 2013 Jan;257(1):102-7. doi: 10.1097/SLA.0b013e318260a8e6.


Fetal maternal immunity and antileukemia activity in cord-blood transplant recipients.

Milano F, Nelson JL, Delaney C.

Bone Marrow Transplant. 2013 Mar;48(3):321-2. doi: 10.1038/bmt.2012.157. Epub 2012 Sep 24. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk